DUBLIN--(BUSINESS WIRE)--The "Alcohol Addiction - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Alcohol Addiction - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Alcohol Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 2, 11, 5, 1, 20 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.
Alcohol Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Introduction
- Alcohol Addiction - Overview
- Alcohol Addiction - Therapeutics Development
- Alcohol Addiction - Therapeutics Assessment
- Alcohol Addiction - Companies Involved in Therapeutics Development
- Alcohol Addiction - Drug Profiles
- Alcohol Addiction - Dormant Projects
- Alcohol Addiction - Discontinued Products
- Alcohol Addiction - Product Development Milestones
- Appendix
Companies Mentioned
- AbbVie Inc
- Addex Therapeutics Ltd
- Adial Pharmaceuticals LLC
- Arbor Pharmaceuticals LLC
- AstraZeneca Plc
- BioCorRx Inc
- Bionex Pharmaceuticals LLC
- Bioprojet SCR
- Chronos Therapeutics Ltd
- Corcept Therapeutics Inc
- Curemark LLC
- Eli Lilly and Co
- Ethypharm SA
- H. Lundbeck AS
- Heptares Therapeutics Ltd
- Indivior Plc
- Johnson & Johnson
- Kinnov Therapeutics SAS
- Kyorin Pharmaceutical Co Ltd
- Lohocla Research Corp
- Mapreg SAS
- Montisera Ltd
- Omeros Corp
- Opiant Pharmaceuticals Inc
- Pfizer Inc
- Silence Therapeutics Plc
- SK Biopharmaceuticals Co Ltd
- Syntropharma Ltd
- Tonix Pharmaceuticals Holding Corp
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/f7b6lm/alcohol_addiction?w=4
